LeserbriefKommentar
Nirmatrelvir–Ritonavir for Covid-19 in Higher-Risk Outpatients
New England Journal of Medicine · 06.08.2026 · 395 (6) · 621-622
DOI: 10.1056/nejmc2607311 ↗Kurz gefasst
Leserbrief in der Zeitschrift New England Journal of Medicine, erschienen am 06.08.2026. Verfasst von P Dileep Kumar. Beteiligte Einrichtung: McLaren Hospital, Port Huron, MI. Die Arbeit nennt 6 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- McLaren Hospital, Port Huron, MI.
Zitieren
APA
Kumar, P. D. (2026). Nirmatrelvir–Ritonavir for Covid-19 in Higher-Risk Outpatients. New England Journal of Medicine, 395(6), 621-622. https://doi.org/10.1056/nejmc2607311
Vancouver
Kumar PD. Nirmatrelvir–Ritonavir for Covid-19 in Higher-Risk Outpatients. New England Journal of Medicine. 2026;395(6):621-622. doi:10.1056/nejmc2607311
BibTeX
@article{Kumar2026,
author = {Kumar, P Dileep},
title = {Nirmatrelvir–Ritonavir for Covid-19 in Higher-Risk Outpatients},
journal = {New England Journal of Medicine},
year = {2026},
volume = {395},
number = {6},
pages = {621--622},
doi = {10.1056/nejmc2607311}
}
EUVIMED